Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of highly actionable mutations among Indian patients with advanced non-small cell lung cancer: A systematic review and meta-analysis.

Asia-Pacific journal of clinical oncology - 1 Feb 2023

Raman Ruchir, Ramamohan Varun, Rathore Anurag, Jain Deepali, Mohan Anant, Vashistha Vishal

Abstract excerpt

BACKGROUND: Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality in India. To clarify rates of actionable mutations, and thereby identify opportunities to improve the delivery of best available care for a large volume of patients, a comprehensive review of available data is warranted. METHODS: Studies that reported prevalence of any actionable gene variant among adult Indian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Mutation

Share to Prevalence

Source

Identifiers

PMID: 35634796
DOI: 10.1111/ajco.13802

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of highly actionable mutations among Indian patients with advanced non-small cell lung cancer: A systematic review and meta-analysis.PMID 35634796Read ↗

The landscape of actionable genomic alterations in lung adenocarcinomas in IndiaSemantic proximity Read ↗

Molecular epidemiology and clinical characteristics of epidermal growth factor receptor mutations in NSCLC: A single-center experience from India.Semantic proximity Read ↗

Actionable Mutation Profiles of Non-Small Cell Lung Cancer patients from Vietnamese population.Semantic proximity Read ↗

A study of therapy targeted EGFR/ALK mutations in Indian patients with lung adenocarcinoma: A clinical and epidemiological studySemantic proximity Read ↗

Mutational Analysis of EGFR Mutations in Non-Small Cell Lung Carcinoma-An Indian Perspective of 212 Patients.Semantic proximity Read ↗

Molecular characterization of non-small cell lung cancer tumors in Latin American patients from Brazil, Chile and Peru uncovers novel potentially driver mutationsSemantic proximity Read ↗

Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients.Semantic proximity Read ↗

Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients.Semantic proximity Read ↗

Somatic gene mutations and their association with treatment outcomes among Indo-Asian Lung Cancer patients.Semantic proximity Read ↗

Next generation sequencing in lung cancer: An initial experience from India.Semantic proximity Read ↗

Actionable mutations in non-small cell lung cancer in patients at hospital de Especialidades Eugenio Espejo, Ecuador 2017-2020.Semantic proximity Read ↗

Drug-sensitive FGFR3 mutations in lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.